Results 91 to 100 of about 4,121 (170)

Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins. [PDF]

Toxins (Basel)
Misra R, Gupta R, Nayyar N, Baweja R, Sharma V, Singh Y, Baweja R.   +6 more
europepmc   +1 more source

Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance. [PDF]

Front Pharmacol
Wang X, Pešić M, Podolski-Renić A.
europepmc   +1 more source

Proteoglycans as Regulators of Receptor Trafficking and Spatial Signaling in Cancer. [PDF]

Cancers (Basel)
Berdiaki A, Konstantaraki M, Ajlan Z, Marmara M, Tsatsakis A, Tzanakakis G, Nikitovic D.   +6 more
europepmc   +1 more source

An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]

Int J Mol Sci
Narbona J, Lázaro-Gorines R, Gutiérrez-Carmona A, López-Rodríguez JC, Villalba M, Lacadena J.   +5 more
europepmc   +1 more source

Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy. [PDF]

Front Microbiol
Wang Q, Cao R, Xie Y, Zhang Z, Li X, Zhang Y, Luo H, Yao H, Xue P, Ni S.   +9 more
europepmc   +1 more source

Editorial: Metabolic engineering and synthetic biology for sustainable microbial cell factories. [PDF]

Front Microbiol
Sankaranarayanan M, Loganathan K, Pasotti L.   +2 more
europepmc   +1 more source

Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study. [PDF]

Int J Mol Sci
Klimczak A, Krawczenko A, Stamnitz S, Bielawska-Pohl A, Piotrowska P, Grzelenska H, Wypychowska A, Kisielewicz A, Mielecki M, Borowski R, Olejniczak M, Pajak-Tarnacka B.   +11 more
europepmc   +1 more source

Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]

Iran J Pharm Res
Faraz A, Amani J, Arbabian S, Zare Karizi S, Bikhof Torbati M.   +4 more
europepmc   +1 more source

Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin. [PDF]

Cancers (Basel)
Chen P, Zhang Y, Bordeau BM, Balthasar JP.   +3 more
europepmc   +1 more source

Ribosome-Inactivating Proteins from <i>Salsola soda</i> L. and <i>Saponaria officinalis</i> L. Are Promising Candidates for Targeted Therapy of Colon Cancer. [PDF]

Biomedicines
Biscotti F, Ragucci S, Bortolotti M, Falà F, Perrone C, Landi N, Bolognesi A, Di Maro A, Polito L.   +8 more
europepmc   +1 more source